Russian authorities have registered an intravenous solution to treat Covid-19, TASS news agency reports, citing the developers. The manufacturer says the remedy is designed to directly fight the coronavirus.
Dubbed Areplivir, the “first direct-acting intravenous solution for treatment of Covid-19 in Russia” has been registered by the authorities, its developer Promomed told TASS on Friday. The company added that the drug would be available for use in hospitals before year’s end.
Continue reading https://on.rt.com/bksc